Dermal fillers are a popular trend that was once considered taboo for women outside of Hollywood. Before it became trendy, many women hadn’t even heard of dermal fillers, apart from Botox, which also ...

Patients interested in learning more about JUVÉDERM ® VOLUMA ® XC for temple hollowing are encouraged to enroll in Allē, the Allergan Aesthetics loyalty rewards program. In serving more than seven ...

Q. What are the differences between Sculptra and Voluma? Which one do you recommend? A. Sculpture and Voluma are both cosmetic treatments used for facial enhancement, but they differ significantly.

This marks the first time that a hyaluronic acid dermal filler has received FDA approval for temple hollowing. Allergan Aesthetics, an AbbVie company, announced that the FDA has approved Juvéderm ...

The US Food and Drug Administration (FDA) has approved Juvéderm Voluma XC (Allergan) to correct age-related volume deficits in the midface in adults aged 21 years and older, the company announced ...

The Food and Drug Administration has approved the hyaluronic acid dermal filler Juvéderm Voluma XC for injection in the temple region to improve moderate to severe temple hallowing in individuals over ...

April 30 (Reuters) - Reviewers for the U.S. Food and Drug Administration said Allergan Inc's dermal filler, Juvéderm Voluma XC, was effective in correcting volume deficit in the middle of the face at ...

Dr. Deborah H. Atkin, MD - Dermatologist in San Diego Click here for high-resolution version DEL MAR, CA--(Marketwired - Jan 21, 2014) - Dr. Deborah H. Atkin, a dermatologist in San Diego, has added ...

IRVINE, Calif., Aug. 1, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the first ever JUVÉDERM® Day on Wednesday, August 16, 2023. The celebration recognizes the ...

As men and women age, more and more are turning to dermal fillers to combat wrinkles and facial volume/collagen loss. Olga Voloshina, nurse practitioner at Northwest Aesthetics, discusses the ...